Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Jakubowski

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Blood|January 15, 1990
Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudinJ A Jakubowski, J M Maraganore
Blood|July 1, 1988
The pathophysiology and clinical relevance of platelet heterogeneityC B Thompson, J A Jakubowski
Thrombosis Research|January 1, 1979
Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular diseaseJ A Jakubowski, N G Ardlie
Atherosclerosis|November 1, 1978
Modification of human platelet function by a diet enriched in saturated or polyunsaturated fatJ A Jakubowski, N G Ardlie
Thrombosis Research|March 1, 1980
Cyclic AMP-independent inhibition of human platelet function by eicosapentaenoic acidJ A Jakubowski, N G Ardlie
Arteriosclerosis (Dallas, Tex.)|July 1, 1988
Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitroJ A Jakubowski, R Vaillancourt, D Deykin
Thrombosis Research|May 15, 1986
Effect of streptozotocin-induced diabetes on prostaglandin production by rat cerebral microvesselsH E Wey, J A Jakubowski, D Deykin
Biochimica Et Biophysica Acta|April 15, 1988
Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2R M Kramer, J A Jakubowski, D Deykin
Biochimica Et Biophysica Acta|October 3, 1986
Incorporation and redistribution of arachidonic acid in diacyl and ether phospholipids of bovine aortic endothelial cellsH E Wey, J A Jakubowski, D Deykin
British Journal of Haematology|August 1, 1983
Inactivation of prostacyclin (PGI2) by erythrocytesJ A Jakubowski, C B Thompson, D Deykin
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Blood|January 15, 1990
Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudinJ A Jakubowski, J M Maraganore
Blood|July 1, 1988
The pathophysiology and clinical relevance of platelet heterogeneityC B Thompson, J A Jakubowski
Thrombosis Research|January 1, 1979
Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular diseaseJ A Jakubowski, N G Ardlie
Atherosclerosis|November 1, 1978
Modification of human platelet function by a diet enriched in saturated or polyunsaturated fatJ A Jakubowski, N G Ardlie
Thrombosis Research|March 1, 1980
Cyclic AMP-independent inhibition of human platelet function by eicosapentaenoic acidJ A Jakubowski, N G Ardlie
Arteriosclerosis (Dallas, Tex.)|July 1, 1988
Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitroJ A Jakubowski, R Vaillancourt, D Deykin
Thrombosis Research|May 15, 1986
Effect of streptozotocin-induced diabetes on prostaglandin production by rat cerebral microvesselsH E Wey, J A Jakubowski, D Deykin
Biochimica Et Biophysica Acta|April 15, 1988
Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2R M Kramer, J A Jakubowski, D Deykin
Biochimica Et Biophysica Acta|October 3, 1986
Incorporation and redistribution of arachidonic acid in diacyl and ether phospholipids of bovine aortic endothelial cellsH E Wey, J A Jakubowski, D Deykin
British Journal of Haematology|August 1, 1983
Inactivation of prostacyclin (PGI2) by erythrocytesJ A Jakubowski, C B Thompson, D Deykin
Pageof 8